Eaton Vance Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,057
Closed -$742K 1638
2022
Q1
$742K Buy
+23,057
New +$742K ﹤0.01% 1429